Skip to main
CCRN

CCRN Stock Forecast & Price Target

CCRN Analyst Ratings

Based on 5 analyst ratings
Hold
Strong Buy 20%
Buy 0%
Hold 80%
Sell 0%
Strong Sell 0%

Bulls say

Cross Country Healthcare is expected to see strong growth in the coming years due to recent investments in revenue-producing employees, positive market conditions, and a robust sales pipeline. However, the company is facing risks such as potential loss of significant MSP customers and the impact of telemedicine on physician staffing. Despite the recent acquisition offer from Knox Lane, the company's fundamentals suggest strong potential for growth in the long term.

Bears say

Cross Country Healthcare is a technology-enabled healthcare workforce solutions provider that saw a 2% sequential increase in revenue in Q1/26, primarily driven by its Nurse and Allied Staffing segment. However, with its pending acquisition by Knox Lane at a price of $13.25 per share, its stock price is currently trading very close to the offer price, leading us to maintain our MARKET PERFORM investment rating. We see the potential for synergies between All Star Healthcare Solutions and Cross Country's multi-segment operations, further boosting Knox Lane's ambitions in the $20+ billion U.S. healthcare staffing market. However, it is worth noting that the expected demand rebound in the industry may not be immediate, which could pose challenges for Cross Country's growth prospects in the near future.

CCRN has been analyzed by 5 analysts, with a consensus rating of Hold. 20% of analysts recommend a Strong Buy, 0% recommend Buy, 80% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cross Country Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cross Country Healthcare (CCRN) Forecast

Analysts have given CCRN a Hold based on their latest research and market trends.

According to 5 analysts, CCRN has a Hold consensus rating as of Jun 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12.55, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12.55, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cross Country Healthcare (CCRN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.